The Leadership Team at Swedish Orphan Biovitrum (Sobi) is responsible for guiding the strategic direction of the company, ensuring the development and delivery of innovative treatments for rare diseases. They collaborate across various functions, including finance, medical affairs, and patient engagement, to drive decision-making, optimize product portfolios, and foster external partnerships, all aimed at transforming patient outcomes and enhancing community engagement.
View all